| (x EUR million) |
2016 |
2015 |
2014 |
| Revenue |
1,775.9 |
2,363.0 |
2,572.2 |
| - reported growth |
(24.8%) |
(8.1%) |
6.1% |
| - currency comparable growth |
(22.7%) |
(17.3%) |
5.9% |
| EBITDA (excluding exceptional items) |
189.5 |
353.0 |
372.7 |
| EBIT (excluding exceptional items) |
8.5 |
113.1 |
81.4 |
| EBIT |
(218.7) |
(249.9) |
(548.6) |
| EBIT margin (excluding exceptional items) |
0.5% |
4.8% |
3.2% |
| EBIT margin |
(12.3%) |
(10.6%) |
(21.3%) |
| Net result |
(308.9) |
(372.5) |
(457.6) |
|
|
|
|
| Backlog next 12 months |
1,169.6 |
1,323.4 |
1,575.5 |
| - reported growth |
(11.6%) |
(16.0%) |
(8.6%) |
| - currency comparable growth |
(11.6%) |
(20.4%) |
(14.8%) |
|
|
|
|
| Cash flow from operating activities after investments |
186.1 |
314.7 |
42.4 |
| Capex |
92.5 |
160.5 |
280.2 |
| Capital employed |
1,341.2 |
1,689.7 |
2,230.6 |
| Return on capital employed |
(0.7%) |
3.9% |
1.3% |
| Net debt/EBITDA |
1.1 |
1.6 |
2.2 |
|
|
|
|
| Earnings per share (x EUR 1) |
(3.82) |
(4.60) |
(5.65) |
| Dividend per share for year under review (x EUR 1) |
0.00 |
0.00 |
0.00 |
|
|
|
|
| Number of employees (at year-end) |
10,530 |
11,960 |
13,537 |
| Lost time injury frequency (x million hours) |
0.67 |
0.45 |
0.74 |